ASTRAZENECA PLC (AZN)
Clinical trial NCT07044336 updates: 1. primary completion date: 2028-01-20 → 2027-10-15 2. enrollment: 700 → 800 participants
Clinical trial NCT07044336 updates: 1. primary completion date: 2028-01-20 → 2027-10-15 2. enrollment: 700 → 800 participants
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical